Palonosetron Hydrochloride

CAS 135729-61-2 15 current records 4 historicalSmall Molecule

Who holds supplier records for Palonosetron Hydrochloride? 15 organisations hold a current record for Palonosetron Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), Switzerland (2), Netherlands (1), Spain (1) and 2 other countries (2); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Palonosetron Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/palonosetron-hydrochloride

Reading the evidence

  • 15 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (15)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Palonosetron Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Palonosetron Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Palonosetron Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
ROLABO OUTSOURCING, S.L. ZaragozaES
CEP 2026-259 - Rev 01
Palonosetron hydrochloride
Sept 2026Inspected Dec 2023
Spain
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2026-208 - Rev 00
Palonosetron hydrochloride
Jul 2026—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Palonosetron Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Palonosetron Hydrochloride is a serotonin 5-HT3 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting. It is a second-generation drug with a strong affinity for the 5-HT3 receptor and long half-life.

Chemical identity

IUPAC name
(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one;hydrochloride
Canonical SMILES
C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5.Cl
InChIKey
OLDRWYVIKMSFFB-SSPJITILSA-N
Synonyms
Aloxi API, aloxi, palonocetron hydrochloride, palonosetron (as hydrochloride), palonosetron hcl, rs-25259-197

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-3 Receptor Antagonist
Mechanism of action
Serotonin 3 Receptor Antagonists

Therapeutic areas

AntiemeticsGastroenterology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Palonosetron Hydrochloride?

15 organisations hold an active US FDA Type II Drug Master File or a CEP for Palonosetron Hydrochloride: TAPI NL BV (Netherlands), ROLABO OUTSOURCING SL (Spain), WAVELENGTH ENTERPRISES LTD (Israel), ALP PHARM BEIJING CO LTD, APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India) and Emcure Pharmaceuticals Limited (India), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Palonosetron Hydrochloride Drug Master Files are active?

TAPI NL BV (DMF 21749, 23332), ROLABO OUTSOURCING SL (DMF 24497), WAVELENGTH ENTERPRISES LTD (DMF 24798), ALP PHARM BEIJING CO LTD (DMF 23209), APITORIA PHARMA PRIVATE LTD (DMF 25976), Cipla Limited (DMF 27528), Dr. Reddy's Laboratories Ltd. (DMF 23590) and Emcure Pharmaceuticals Limited (DMF 24784) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Palonosetron Hydrochloride records mean?

4 organisations have only inactive Type II DMFs for Palonosetron Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Palonosetron Hydrochloride have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Palonosetron Hydrochloride on the EDQM register, including ROLABO OUTSOURCING, S.L. Zaragoza (ES) and WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Palonosetron Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Palonosetron Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.